Sjs Investment Consulting Inc. Journey Medical Corp Transaction History
Sjs Investment Consulting Inc.
- $647 Million
- Q3 2025
A detailed history of Sjs Investment Consulting Inc. transactions in Journey Medical Corp stock. As of the latest transaction made, Sjs Investment Consulting Inc. holds 15,000 shares of DERM stock, worth $110,250. This represents 0.02% of its overall portfolio holdings.
Number of Shares
15,000Holding current value
$110,250% of portfolio
0.02%Shares
1 transactions
Others Institutions Holding DERM
# of Institutions
62Shares Held
7MCall Options Held
0Put Options Held
0-
Tang Capital Management LLC San Diego, CA1.85MShares$13.6 Million0.8% of portfolio
-
Wasatch Advisors Inc Salt Lake City, UT1.15MShares$8.47 Million0.04% of portfolio
-
B. Riley Securities, Inc. Los Angeles, CA865KShares$6.36 Million0.36% of portfolio
-
Vanguard Group Inc Valley Forge, PA565KShares$4.15 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA262KShares$1.93 Million0.0% of portfolio
About Journey Medical Corp
- Ticker DERM
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 11,596,500
- Market Cap $85.2M
- Description
- Journey Medical Corporation focuses on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States. The company's marketed products include Qbrexza, a medicated cloth towelette for the treatment of primary axillary hyperhidrosis; Accutane, an oral isotretinoin drug to treat...